Removing symbiotic Wolbachia bacteria specifically inhibits oogenesis in a parasitic wasp.
Wolbachia are bacteria that live in the cells of various invertebrate species to which they cause a wide range of effects on physiology and reproduction. We investigated the effect of Wolbachia infection in the parasitic wasp, Asobara tabida Nees (Hymenoptera, Braconidae). In the 13 populations tested, all individuals proved to be infected by Wolbachia. The removal of Wolbachia by antibiotic treatment had a totally unexpected effect-aposymbiotic female wasps were completely incapable of producing mature oocytes and therefore could not reproduce. In contrast, oogenesis was not affected in treated Asobara citri, a closely related species that does not harbor Wolbachia. No difference between natural symbiotic and cured individuals was found for other adult traits including male fertility, locomotor activity, and size, indicating that the effect on oogenesis is highly specific. We argue that indirect effects of the treatments used in our study (antibiotic toxicity or production of toxic agents) are very unlikely to explain the sterility of females, and we present results showing a direct relationship between oocyte production and Wolbachia density in females. We conclude that Wolbachia is necessary for oogenesis in these A. tabida strains, and this association would seem to be the first example of a transition from facultative to obligatory symbiosis in arthropod-Wolbachia associations.
Dedeine
F
F
Biométrie et Biologie Evolutive, Unité Mixte de Recherche-Centre National de la Recherche Scientifique, 5558 Université Lyon I, 43, Boulevard du 11 Novembre 1918, 69622 Villeurbanne Cédex, France. dedeine@biomserv.univ-lyon1.fr
Vavre
F
F
Fleury
F
F
Loppin
B
B
Hochberg
M E
ME
Bouletreau
M
M
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D008070:Lipopolysaccharides; D008297:Male; D009865:Oocytes; D009866:Oogenesis / Q000187:drug effects / Q000502:physiology*; D012293:Rifampin / Q000494:pharmacology; D013559:Symbiosis; D014863:Wasps / Q000187:drug effects / Q000382:microbiology / Q000502:physiology*; D020577:Wolbachia / Q000235:genetics / Q000502:physiology*
D000900:Anti-Bacterial Agents; D008070:Lipopolysaccharides; D012293:Rifampin